Details for Patent: 9,180,090

Which drugs does patent 9,180,090 protect, and when does it expire?

Patent 9,180,090 protects QUZYTTIR and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 9,180,090

Patent landscape, scope, and claims:

Title:	Non-sedating antihistamine injection formulations and methods of use thereof
Abstract:	Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions.
Inventor(s):	Du; Jie (Lansdale, PA)
Assignee:	JDP THERAPEUTICS, INC. (Lansdale, PA)
Application Number:	13/644,290
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 9,180,090

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Jdp	QUZYTTIR	cetirizine hydrochloride	SOLUTION;INTRAVENOUS	211415-001	Oct 4, 2019		RX	Yes	Yes						TREATMENT OF ACUTE URTICARIA

International Family Members for US Patent 9,180,090

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010266103
Canada	2803987
European Patent Office	2477634